PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
ALHC vs. CLOV
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between ALHC and CLOV is 0.34, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.3

Performance

ALHC vs. CLOV - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Alignment Healthcare Holdings, LLC (ALHC) and Clover Health Investments, Corp. (CLOV). The values are adjusted to include any dividend payments, if applicable.

0.00%50.00%100.00%150.00%200.00%SeptemberOctoberNovemberDecember2025
72.14%
162.91%
ALHC
CLOV

Key characteristics

Sharpe Ratio

ALHC:

1.80

CLOV:

4.08

Sortino Ratio

ALHC:

2.52

CLOV:

4.19

Omega Ratio

ALHC:

1.33

CLOV:

1.50

Calmar Ratio

ALHC:

1.48

CLOV:

3.52

Martin Ratio

ALHC:

8.25

CLOV:

19.18

Ulcer Index

ALHC:

15.04%

CLOV:

17.84%

Daily Std Dev

ALHC:

69.04%

CLOV:

83.92%

Max Drawdown

ALHC:

-83.61%

CLOV:

-97.19%

Current Drawdown

ALHC:

-43.56%

CLOV:

-80.18%

Fundamentals

Market Cap

ALHC:

$2.91B

CLOV:

$2.31B

EPS

ALHC:

-$0.76

CLOV:

-$0.19

Total Revenue (TTM)

ALHC:

$2.00B

CLOV:

$1.03B

Gross Profit (TTM)

ALHC:

$210.35M

CLOV:

$465.18M

EBITDA (TTM)

ALHC:

-$58.68M

CLOV:

-$22.84M

Returns By Period

In the year-to-date period, ALHC achieves a 36.80% return, which is significantly lower than CLOV's 39.37% return.


ALHC

YTD

36.80%

1M

36.80%

6M

72.15%

1Y

137.50%

5Y*

N/A

10Y*

N/A

CLOV

YTD

39.37%

1M

39.37%

6M

162.87%

1Y

339.00%

5Y*

N/A

10Y*

N/A

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

ALHC vs. CLOV — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ALHC
The Risk-Adjusted Performance Rank of ALHC is 8888
Overall Rank
The Sharpe Ratio Rank of ALHC is 9191
Sharpe Ratio Rank
The Sortino Ratio Rank of ALHC is 8787
Sortino Ratio Rank
The Omega Ratio Rank of ALHC is 8787
Omega Ratio Rank
The Calmar Ratio Rank of ALHC is 8686
Calmar Ratio Rank
The Martin Ratio Rank of ALHC is 8989
Martin Ratio Rank

CLOV
The Risk-Adjusted Performance Rank of CLOV is 9797
Overall Rank
The Sharpe Ratio Rank of CLOV is 9999
Sharpe Ratio Rank
The Sortino Ratio Rank of CLOV is 9797
Sortino Ratio Rank
The Omega Ratio Rank of CLOV is 9595
Omega Ratio Rank
The Calmar Ratio Rank of CLOV is 9696
Calmar Ratio Rank
The Martin Ratio Rank of CLOV is 9797
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

ALHC vs. CLOV - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Alignment Healthcare Holdings, LLC (ALHC) and Clover Health Investments, Corp. (CLOV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for ALHC, currently valued at 1.80, compared to the broader market-2.000.002.001.804.08
The chart of Sortino ratio for ALHC, currently valued at 2.52, compared to the broader market-4.00-2.000.002.004.002.524.19
The chart of Omega ratio for ALHC, currently valued at 1.33, compared to the broader market0.501.001.502.001.331.50
The chart of Calmar ratio for ALHC, currently valued at 1.48, compared to the broader market0.002.004.006.001.483.52
The chart of Martin ratio for ALHC, currently valued at 8.25, compared to the broader market0.0010.0020.008.2519.18
ALHC
CLOV

The current ALHC Sharpe Ratio is 1.80, which is lower than the CLOV Sharpe Ratio of 4.08. The chart below compares the historical Sharpe Ratios of ALHC and CLOV, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.001.002.003.004.005.00SeptemberOctoberNovemberDecember2025
1.80
4.08
ALHC
CLOV

Dividends

ALHC vs. CLOV - Dividend Comparison

Neither ALHC nor CLOV has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

ALHC vs. CLOV - Drawdown Comparison

The maximum ALHC drawdown since its inception was -83.61%, smaller than the maximum CLOV drawdown of -97.19%. Use the drawdown chart below to compare losses from any high point for ALHC and CLOV. For additional features, visit the drawdowns tool.


-90.00%-80.00%-70.00%-60.00%-50.00%-40.00%SeptemberOctoberNovemberDecember2025
-43.56%
-80.18%
ALHC
CLOV

Volatility

ALHC vs. CLOV - Volatility Comparison

Alignment Healthcare Holdings, LLC (ALHC) and Clover Health Investments, Corp. (CLOV) have volatilities of 14.68% and 14.49%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.


5.00%10.00%15.00%20.00%25.00%30.00%35.00%40.00%SeptemberOctoberNovemberDecember2025
14.68%
14.49%
ALHC
CLOV

Financials

ALHC vs. CLOV - Financials Comparison

This section allows you to compare key financial metrics between Alignment Healthcare Holdings, LLC and Clover Health Investments, Corp.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab